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Objective: Recent studies suggest that psychotic-like experiences may also act as markers for non-psychotic
psychiatric disorders, which may indicate that the focus of research in individuals at high risk (HR) for psy-
chosis needs updating. In this study we thoroughly examined the clinical and functional characteristics of a
consecutive cohort of young people at HR for psychosis and compared them to a matched sample of healthy
volunteers.
Method: Between February 2010 and September 2012 60 help-seeking HR individuals, aged 16–35,
were recruited from CAMEO Early Intervention in Psychosis Service, Cambridgeshire, UK. Forty-ﬁve age-
and gender-matched healthy volunteers were randomly recruited from the same geographical area.
Sociodemographic, psychiatric morbidity, functioning and quality of life measures were compared between
both groups.
Results: HR individuals suffered a wide range of DSM-IV psychiatric disorders, mainly within the affective and
anxiety diagnostic spectra. In comparison to healthy volunteers, young people at HR reportedmore suicidal ide-
ation/intention, depressive and anxiety symptoms and presented with remarkably poor functioning and quality
of life.
Conclusion: The presence of co-morbid moderate or severe depressive and anxiety symptoms was common in
our sample of young people at enhanced risk for psychosis. A HR mental state may be associated not only
with an increased risk for psychosis, but also other psychiatric disorders. Our ﬁndings may have implications
for the future implementation of therapeutic interventions that this population could beneﬁt from.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
There has been a decline in transition rates into psychosis in cohorts
of individuals at high risk (HR) of developing psychosis across different
centres worldwide, over the last few years (Yung et al., 2007). Differenteck Depression Inventory, Ver-
ptoms; CAARMS, Comprehen-
pisode Psychosis; GAF, Global
nchester Short Assessment of
c Interview; PAF, Postcode Ad-
le; YBOCS, Yale-Brown Obses-
Rating Scale.
, Fulbourn Hospital, Fulbourn,
+44 1223884362.
.V. Open access under CC BY-NC-ND lpsychological and pharmacological interventions have not signiﬁcantly
reduced transitions in recent randomised controlled trials (McGorry et
al., 2012; Morrison et al., 2012). This may suggest that the focus of re-
search in this population group needs updating.
Growing evidence is indicating that psychosismay lie on a continuum,
with mild psychotic symptoms or psychotic-like experiences at one end
and schizophrenia and related psychotic disorders at the other (Kendler
et al., 1996; van Os et al., 2001; Dhossche et al., 2002; Johns et al., 2004;
van Os et al., 2009). Recent studies including population-based samples
also suggest that nearly 80% of the adolescents who report psychotic-
like symptoms may have at least one other psychiatric disorder
(Kelleher et al., 2012a, 2012b). Furthermore, co-presence of psychotic
symptoms in adolescents and young adults with disorders of anxiety
and depression appears to bemore prevalent than previously considered,
and an etiological and functionally relevant feature (Wigman et al., 2012).
Psychotic experiences may also act as markers for non-psychotic
psychiatric disorders in individuals at clinical HR for psychosis.
Fusar-Poli et al. (2012) found that 73% of the HR individuals recruitedicense.
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with major depression as predominant diagnosis, followed by anxiety
disorders. Similarly, Salokangas et al. (2012) identiﬁed comorbid psy-
chiatric disorders in almost 80% of their HR sample (n = 245).
It is therefore important to thoroughly understand the type and
severity of psychopathology in people at HR for psychosis in order
to develop speciﬁc care pathways and interventions that this group
could likely beneﬁt from. To achieve this goal, comparisons with
healthy volunteers to evaluate the overall psychiatric morbidity and
subsequent impact on quality of life and functioning in HR individuals
are highly recommended. It is noteworthy that these comparisons are
still very limited in the current scientiﬁc literature, with only a hand-
ful of studies assessing the real impact of HR mental states on func-
tioning and quality of life (Velthorst et al., 2010; Granö et al., 2011;
Fusar-Poli et al., 2012).
The aims of this study were to further delineate the clinical man-
ifestations of young people at HR for psychosis at the time of their re-
ferral to mental health services and evaluate their level of global
functioning, occupational status and quality of life in comparison to
a sample of healthy volunteers recruited from the same geographical
area.2. Methods
We compared demographic, psychiatric morbidity, functioning
and quality of life measures between help-seeking HR individuals
and healthy volunteers recruited from Cambridgeshire, UK.2.1. Setting
CAMEO (http://www.cameo.nhs.uk) is an early intervention service
in psychosis which offers management for people aged 14–35 years
suffering from ﬁrst-episode psychosis (FEP) in Cambridgeshire, UK.
CAMEO also accepts referrals of people at HR aged 16–35. Referrals
are accepted from multiple sources including general practitioners,
other mental health services, school and college counsellors, relatives
and self-referrals (Cheng et al., 2011).2.2. Sample
A consecutive cohort of 60 help-seeking individuals, aged 16–35, re-
ferred to CAMEO Early Intervention in Psychosis Service from February
2010 to September 2012 met criteria for HR, according to the Compre-
hensive Assessment of At Risk Mental States (CAARMS) (Yung et al.,
2005). From this assessment, HR individuals were divided into three
groups based onwhether they weremainly characterised by: i) vulner-
ability traits (family history of psychosis in ﬁrst degree relative plus
signiﬁcant drop in functioning levels within past 12 months), ii) atten-
uated psychotic symptoms, or iii) brief limited intermittent psychotic
symptoms (BLIPS). In our sample, all individuals fulﬁlled criteria for
the attenuated psychotic symptoms' group. Seven individuals (11.7%)
also qualiﬁed for the vulnerability traits' group. Intake exclusion criteria
included: i) acute intoxication or withdrawal associated with drug or
alcohol abuse or any delirium, ii) conﬁrmed intellectual disability
(Wechsler Adult Intelligence Scale — tested IQ b70), or iii) prior total
treatment with antipsychotics for more than one week.
During the same period (February 2010–September 2012), a ran-
dom sample of 45 healthy volunteers was recruited by post, using the
Postcode Address File (PAF®) provided by Royal Mail, UK. Healthy
volunteers interested in the study could only participate if they
were aged 16–35, resided in the same geographical area as HR partic-
ipants (Cambridgeshire), and did not have previous contact with
mental health services. They were recruited for the exclusive purpose
of this research.2.3. Ethical approval
Ethical approval was granted by the Cambridgeshire East Research
Ethics Committee.
2.4. Measures
All participants were assessed with sociodemographic (age, gen-
der, ethnicity, education level, marital status, and living accommoda-
tion), psychiatric morbidity, functioning and quality of life measures
at the time of their referral to CAMEO. The assessments were carried
out by senior research clinicians trained in each of the measurement
tools. HR participants were also interviewed by senior trained psychi-
atrists working in CAMEO, using the Mini International Neuropsychi-
atric Interview (MINI), Version 6.0.0, a brief structured diagnostic
interview for DSM-IV Axis I psychiatric disorders (Sheehan et al.,
1998).
The Positive and Negative Syndrome Scale (PANSS) for psychotic
symptoms was employed to capture the severity of positive symp-
toms (7 items), negative symptoms (7 items) and general psychopa-
thology (16 items) in a 7-point scale, with higher scores indicating
greater severity of illness (Kay et al., 1987). Summary score and
sub-domain scores of positive, negative and general psychopathology
symptoms were computed.
The Beck Depression Inventory Version II (BDI-II) (Beck et al.,
1996) and the Beck Anxiety Inventory (BAI) (Beck et al., 1988) were
used to assess depressive and anxiety symptoms respectively. The
BDI-II is a widely used self-complete instrument to assess depressive
symptom severity in the past two weeks. It consists of 21 items rated
on a 4-point scale from absent (0), mild (1), moderate (2) to severe
(3). In addition to item scores, a composite score (range 0–63 points)
was calculated by summing individual items in the BDI-II. The com-
posite score was used to further divide participants into 4 groups in
which scores of 0–13 indicates minimally depressed, 14–19 mildly
depressed, 20–28 moderately depressed and 29–63 severely de-
pressed (Dolle et al., 2012). For the purpose of this study, the BDI-II
item 9 on current suicidal thoughts or wishes was used to categorize
subjects into absent (scoring 0) or present (scoring 1–3) suicidal ide-
ation. Likewise, the BAI is a 21-item self-complete measure of anxiety
symptoms also rated on a 4-point scale, from 0 indicating absent to 3
indicating severe. Individual item scores and composite score (range
0–63) were computed. Participants were further divided into 4
groups according to their BAI composite score: scores of 0–7 indicates
minimal anxiety, 8–14 mild anxiety, 16–25 moderate anxiety, and
26–63 severe anxiety (Beck and Steer, 1993).
Manic symptoms were assessed using the Young Mania Rating
Scale (YMRS) (Young et al, 1978). The scale has 11 items — while 7
items on elevated mood, increased motor activity–energy, sexual in-
terest, sleep, language–thought disorder, appearance and insight
were rated from 0 (absence) to 4 (severe), the remaining 4 items
on irritability, speech, content and disruptive–aggressive behaviour
were rated from 0 (absent) to 8 (severe). A summary score of all
the items of the YMRS was calculated (range 0–60).
The Yale–Brown Obsessive Compulsive Symptom Checklist and Se-
verity Scales (YBOCS) (Goodman et al., 1989) were used to examine
the presence and severity of obsessions and compulsions. The propor-
tion of subjects having obsessions and/or compulsions in each group
was calculated. For those who had at least one obsession and/or com-
pulsion, the mean total severity scores were also generated.
The Global Assessment of Functioning (GAF) is a commonly used
functioning scale in psychiatric research (Hall, 1995). The GAF assesses
global functioning in the past month. Both symptoms and disability di-
mensions were assessed using an impression score of 1 to 100, with 10
points separating each level (Endicott et al., 1976), and lower scores
representing higher severity of symptoms and poorer level of function-
ing respectively. Occupational status was also recorded.
Table 1
Sociodemographic comparison between HR individuals and healthy volunteers.
Sociodemographic characteristics† HR (n = 60) HV (n = 45) p-Value
Age at study entry, years, mean (SD) 20.2 (2.9) 21.4 (3.9) 0.088a
Gender, male, n (%) 31 (51.7) 24 (53.3) 0.866b
Ethnicity, n (%)‡
White 56 (93.3) 41 (91.1) 0.722c
Mixed 2 (3.3) 3 (6.7) 0.649c
Asian 1 (1.7) 1 (2.2) 1.000c
Black 1 (1.7) 0 (0) 1.000c
Education level, n (%) (9)
Primary 5 (9.8) 0 (0) 0.058c
Secondary 26 (51.0) 10 (22.7) 0.006c
Further§ 17 (33.3) 20 (45.5) 0.298c
Higher 3 (5.9) 15 (31.8) 0.001c
Marital status, n (%) (7)
Single 48 (90.6) 33 (73.3) 0.033c
Married/co-habiting 5 (9.4) 11 (24.4) 0.057c
Divorced/dissolved 0 (0) 1 (2.2) 0.459c
Current accommodation type, n (%) (6)
Detached house 13 (24.1) 15 (33.3) 0.372c
Semi-detached house 18 (33.3) 10 (22.2) 0.266c
Terraced house 12 (22.2) 12 (26.7) 0.644c
Flat 4 (7.4) 7 (15.6) 0.219c
Bedsit/studio 1 (1.9) 0 (0) 1.000c
Communal establishment 6 (11.1) 1 (2.2) 0.123c
Current psychiatric medication, n (%) 25 (41.7) 0 (0) b0.00b
Current psychiatric medication type, n (%)⁎
Antipsychotics 0 (0) 0 (0) –
Antidepressants 24 (38.3) 0 (0) b0.001c
Anxiolytics 2 (1.7) 0 (0) 0.505c
Both antidepressants and anxiolytics 1 (1.7) 0 (0) 1.000c
HR = high risk; HV = healthy volunteers; SD = standard deviation; n = number.
†Number of missing observations in brackets.
‡‘White ethnicity’ refers to subjects who are White British, White Irish, or other White
backgrounds. ‘Mixed ethnicity’ refers to those who are White and Black Caribbean,
mixed White and Black African, mixed White and Asian, or any other mixed
backgrounds. ‘Asian ethnicity’ refers to those who are Indian or Chinese. ‘Black
ethnicity’ refers to subject from any Black backgrounds.
§UK National Vocational Qualiﬁcations (NVQs) or A-Levels.
⁎Multiple answers were allowed for those who had any psychiatric medication taken
during study entry.
a Independent t-test.
b Chi-square test.
c Fisher's exact test.
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of Quality of Life (MANSA) (Priebe et al., 1999). The subjective and ob-
jective dimensions of quality of life were captured. For the purpose of
this study, the subjective dimension comprising of the following do-
mainswas analysed: life in general, health, work and education, ﬁnance,
leisure, safety, living situation, social and family relations. Each item is
rated from 1 (worst) to 7 (best possible satisfaction). The overall mean
subjective quality of life score was computed by averaging all the
items in the subjective dimension (Eklund, 2009).
2.5. Statistical analysis
All analyses were performed using version 20 of SPSS (SPSS, Inc.,
Chicago, Illinois). We compared sociodemographic information be-
tween HR individuals and healthy volunteers. Clinical morbidity mea-
sures including PANSS, BDI-II, BAI, YMRS and YBOCS, functioning
measures including GAF and occupational status, as well as subjective
quality of life measured by MANSA were further compared between
the two groups. All comparisons were made using chi-square test
or Fisher's exact test for categorical variables and t-test or Mann–
Whitney U test for continuous variables. A p-value of less than 0.05
represents a signiﬁcant difference.
3. Results
3.1. Sociodemographic proﬁle
The whole study population had a mean age of 20.7 years (SD =
3.4). Gender was nearly evenly split between male (n = 55; 52.4%)
and female (n = 50; 47.6%). Table 1 compares the basic demo-
graphics between HR individuals and healthy volunteers. Both groups
did not differ in age, gender, ethnicity and current accommodation
type. Less HR individuals achieved higher education degrees (p =
0.001) compared to healthy volunteers, and more HR individuals
were single (p = 0.033). A signiﬁcant proportion of HR individuals
were on antidepressant or/and anxiolytic medication (41.7%) at the
time of their ﬁrst contact with CAMEO.
3.2. Psychiatric morbidity
We obtained MINI DSM-IV diagnoses for 55 of the 60 HR individ-
uals. 38 (69.1%) had more than one DSM-IV psychiatric diagnosis,
mainly within the affective and anxiety diagnostic spectra. Primary
diagnoses for this group were ranked as follows: major depressive ep-
isode, current or recurrent (n = 26; 47.3%) > social phobia (n = 7;
12.7%) = generalised anxiety disorder (n = 7; 12.7%) > obsessive
compulsive disorder (n = 5; 9.1%) > bipolar disorder, type II (n =
2; 3.6%) > panic disorder (n = 1; 1.8%) = posttraumatic stress dis-
order (n = 1; 1.8%). Six HR individuals (10.9%) did not fulﬁl enough
criteria for a DSM-IV Axis I diagnosis.
Table 2 shows that HR individuals had higher scores (i.e., greater
symptom severity) in total PANSS and all its sub-domains, including
positive, negative and general psychopathology symptoms compared
with healthy volunteers (all with p b 0.001). However, all scores sug-
gested a “mildly ill” group with regard to psychotic symptoms
(Leucht et al., 2005).
HR individuals also had a higher total BDI-II score (i.e., more de-
pressed) than controls (29.9 ± 12.8 vs. 5.6 ± 5.5, p b 0.001). This
difference was signiﬁcant in all items. We further divided participants
into 4 groups according to their total scores in BDI-II. HR individuals
were signiﬁcantly more likely to be severely or moderately depressed
(54.0% vs. 0%, p b 0.001 and 20.0% vs. 4.5%, p = 0.025, respectively).
We tested if HR individuals who were currently on antidepressants
(n = 24) had a higher baseline BDI-II score than those who were
not on antidepressants (n = 36). However, no difference on the
means of BDI-II sum scores was observed between the two groups(32.7 ± 12.4 vs. 27.8 ± 13.0, p = 0.184). HR individuals had a
72.0% endorsement in suicidal thoughts or intention, as measured
with item 9 of BDI-II, whereas only 9.1% of healthy volunteers had
positive response in this item (p b 0.001).
Similarly, BAI scores showed that HR individuals had more anxiety
symptoms (28.2 ± 11.9 vs. 6.7 ± 5.6, p b 0.001). Indeed, 41 HR indi-
viduals (85.4%) suffered moderate or severe anxiety symptoms.
Although HR individuals had a signiﬁcant higher YMRS score than
healthy volunteers (p b 0.001), the mean score was 3.9 (SD = 4.1),
suggesting subclinical severity.
Approximately 80% of HR individuals had experienced at least one
obsessive symptom. Among those who had any obsession or compul-
sion, the mean of YBOCS total severity score was signiﬁcantly higher
in HR individuals than healthy volunteers (20.1 ± 5.8 vs. 5.3 ± 1.5,
p b 0.001), suggesting moderate and subclinical severity respectively.3.3. Transitions from HR to FEP
After more than one year of follow-up for each individual at HR in
our sample, only 6 (10%) made a transition into FEP. We obtained
MINI DSM-IV diagnoses at baseline for 5 of them. 4 had an initial diag-
nosis of major depression, current or recurrent, and one did not fulﬁl
enough criteria for a DSM-IV mental disorder. None of the HR individ-
uals from this cohort received antipsychotics during the follow-up
Table 2
Clinical comparison between HR individuals and healthy volunteers.
Clinical characteristics† HR (n = 60) HV (n = 45) p-Value
PANSS, mean (SD) (6)
Positive 13.1 (3.2) 7.1 (0.5) b0.001a
Negative 12.4 (5.0) 7.8 (0.9) b0.001a
General psychopathology 32.7 (7.0) 16.3 (1.3) b0.001a
Sum of all items 58.2 (12.1) 31.3 (1.9) b0.001a
BDI-II (11)
Sum of all items, mean (SD) 29.9 (12.8) 5.6 (5.5) b0.001a
Suicidality (score 1–3), n (%) 36 (72.0) 4 (9.1) b0.001b
Depression subgroup, n (%) b0.001b
Minimal (score 0–13) 5 (10.0) 39 (88.6) b0.001b
Mild (score 14–19) 8 (16.0) 3 (6.8) 0.167b
Moderate (score 20–28) 10 (20.0) 2 (4.5) 0.025b
Severe (score 29–63) 27 (54.0) 0 (0) b0.001b
BAI (15)
Sum of all items, mean (SD) 28.2 (11.9) 6.7 (5.6) b0.001a
Anxiety subgroup, n (%) b0.001b
Minimal (score 0–7) 2 (4.2) 29 (67.4) b0.001b
Mild (score 8–15) 5 (10.4) 9 (20.9) 0.165b
Moderate (score 16–25) 12 (25.0) 5 (11.6) 0.102b
Severe (score 26–63) 29 (60.4) 0 (0) b0.001b
YMRS (7)
Sum of all items, mean (SD) 3.9 (4.1) 0.5 (1.2) 0.001a
YBOCS (13)
Having obsession, n (%) 37 (77.1) 2 (4.5) b0.001b
Having compulsion, n (%) 34 (70.8) 1 (2.3) b0.001b
Sum of all items, mean (SD) 20.1 (5.8) 5.3 (1.5) b0.001a
Severity subgroups, n (%) b0.001b
Subclinical (score 0–7) 2 (5.4) 3 (100) 0.001c
Mild (score 8–15) 5 (13.5) 0 (0) 0.001c
Moderate (score 16–23) 20 (54.1) 0 (0) 0.231c
Severe (score 24–31) 9 (24.3) 0 (0) 1.000c
Extreme (score 32–40) 1 (2.7) 0 (0) 1.000c
HR = high risk; HV = healthy controls; SD = standard deviation; n = number;
PANSS = Positive and Negative Syndrome Scale, BDI-II = Beck Depression Inventory,
Version II, BAI = Beck Anxiety Inventory, YMRS = Young Mania Rating Scale,
YBOCS = Yale-Brown Obsessive Compulsive Scale.
†Number of missing observations in brackets.
a Independent t-test.
b Chi-square test.
c Fisher's exact test.
Table 3
Functioning and quality of life comparison between HR individuals and healthy
volunteers.
Functioning and quality of life measures† HR (n = 60) HV (n = 45) p-Value
GAF, mean (SD) (3)
Symptoms 45.4 (8.9) 86.6 (3.8) b0.001a
Disability 48.6 (9.4) 86.7 (3.6) b0.001a
Occupational status, n (%) (7)‡ 0.061b
Unemployed 20 (37.7) 8 (17.8) 0.029b
Employed 16 (30.2) 22 (48.9) 0.058b
Students 17 (32.1) 15 (33.3) 0.895b
MANSA, mean (SD) (11) 3.8 (1.0) 5.6 (0.6) b0.001c
Life as a whole today 3.4 (1.5) 5.6 (1.0) 0.001c
Health 3.5 (1.4) 5.4 (1.1) b0.001c
Present mental health 3.0 (1.4) 6.2 (0.8) b0.001c
Job (if working) 4.1 (1.8) 5.4 (1.4) 0.011c
Not working (if not working) 3.7 (1.7) 4.0 (1.9) 0.532c
Financial situation 3.5 (1.5) 4.6 (1.5) 0.001c
Leisure activities 3.9 (1.9) 5.6 (1.3) b0.001c
Number of friends 4.2 (1.8) 5.8 (1.0) b0.001c
Relationships with friends 4.5 (1.7) 5.7 (0.9) b0.001c
Personal safety 4.0 (1.6) 5.8 (0.9) b0.001c
Accommodation 4.6 (1.7) 6.0 (1.2) b0.001c
People one live with
(if living with other)
4.7 (1.4) 6.1 (0.9) b0.001c
Living alone (if living alone) 4.0 (–) – –
Relationship with family 4.0 (1.4) 5.6 (1.0) b0.001c
Life overall 3.0 (1.4) 5.8 (0.9) b0.001c
HR = high risk; HV = healthy controls; SD = standard deviation; n = number;
GAF = Global Assessment of Functioning; MANSA = Manchester Short Assessment
of Quality of Life.
†Number of missing observations in brackets.
‡Employment status is broadly categorized into 3 groups. ‘Unemployed’ includes
subjects who do not have a job, either they are looking for work, not looking for
work (e.g., housewife), or not being able to work due to medical reasons. ‘Employed’
refers to people who have full/part-time employment, or employed but currently
unable to work. ‘Students’ refer to full/part-time students.
a Mann–Whitney U test.
b Chi-square test.
c Independent t-test.
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i.e. anxiolytics and/or antidepressants, if clinically required.
3.4. Functioning and quality of life
Table 3 compares functioning, employment status, and quality of
life between HR and healthy individuals. HR subjects had poorer func-
tioning, with much lower scores in GAF symptoms and disability than
healthy volunteers (45.4 ± 8.9 vs. 86.6 ± 3.8 and 48.6 ± 9.4 vs.
86.7 ± 3.6, respectively, both with p b 0.001), suggesting that indi-
viduals with HR mental states suffered serious psychiatric symptoms
and any serious impairment in social, occupational or academic func-
tioning. Higher unemployment rate was found in the HR group (37.7%
vs. 17.8%, p = 0.029). HR individuals also reported poorer quality of
life (3.8 ± 1.0 vs. 5.6 ± 0.6, p b 0.001).
4. Discussion
This study compared psychiatric morbidity, functioning and quality
of life between 60 young people at HR for psychosis at the time of
their referral to CAMEO and 45 healthy volunteers. Overall, our ﬁndings
indicate that, beyond psychotic symptoms, there are many other psy-
chopathological conditions that may be interfering in the global func-
tioning of those at HR. More speciﬁcally, our study showed that HR
individuals i) suffered a wide range of psychiatric disorders and mild
psychotic symptoms, ii) reported more suicidal ideation/intention, de-
pressive and anxiety symptoms, and iii) presented with worse levelsof functioning, quality of life and employment status than healthy
volunteers.
These results are in line with previous evidence suggesting a sig-
niﬁcant association between HR mental states and several other psy-
chiatric disorders (Fusar-Poli et al., 2012; Salokangas et al., 2012). We
found that almost 70% of HR individuals in our sample had more than
one DSM-IV Axis I diagnosis. In particular, HR individuals had a statis-
tically signiﬁcant higher prevalence of moderate/severe depression,
anxiety, obsessive–compulsive behaviours, and suicidality than
healthy volunteers.
Our results suggest that individuals at HR are a heterogeneous
group which tends to present with more than one psychiatric disor-
der, mainly depression and/or anxiety-related. Suicidal ideation and
intention were also very prevalent in our HR cohort. Previous studies
have reported similar enhanced risk of suicide in population-based
and clinical samples (Preti et al., 2009; Hutton et al., 2011; Kelleher
et al., 2012a, 2012b). This could be related to a variety of factors,
such as comorbid psychiatric disorders (DeVylder et al., 2012), dis-
tress associated with psychotic-like experiences or mild psychotic
symptoms, especially auditory hallucinations (Lataster et al., 2010),
and mood variability (Palmier-Claus et al., 2012).
Recent studies, both in adolescent and adult populations, have al-
ready shown a strong relationship between HR for psychosis and pres-
ence of comorbid mood and anxiety disorders (Kelleher et al., 2012a,
2012b;Wigman et al., 2012). These associationsmight be even stronger
at earlier stages of development, where psychotic experiences among
young adolescents appear to follow a dose–response pattern in the pre-
diction of a wide variety of future psychopathology (Kelleher et al.,
2012a, 2012b). Interestingly, in contrast with previous ﬁndings that de-
scribed a direct relationship between the degree of psychotic symptoms
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ical HR in our sample were affected by mild psychotic symptoms.
Our ﬁndings highlight the lack of speciﬁcity and predictive value of
psychotic symptoms and carry important implications for clinicians
and researchers in the ﬁeld of psychosis. Psychotic experiences appear
to be common, not only among those patients who suffer from a psy-
chotic illness, but also from other disorders such as depression and anx-
iety (Wigman et al., 2012). Although the causal mechanisms of this
association are not well understood, it has been hypothesized that a
HRmental statemay be an indicativemarker of risk formultiple psychi-
atric disorders (Kelleher et al., 2012a, 2012b). During childhood and ad-
olescence, clinical phenotypes of different psychiatric disorders might
overlap, reaching a greater differentiation throughout adulthood
(Kim-Cohen et al., 2003; Jones, 2013). Also, traumatic events in child-
hood could eventually manifest as psychotic-like symptoms in the con-
text of non-psychotic psychiatric disorders (Kelleher et al., 2013).
Therefore, psychotic and non-psychotic disorders may share similar
risk factors and these could have an impact on neurodevelopmental
processes that may involve genetic, structural and/or neurobiological
changes, resulting in different psychiatric syndromes (Jacobson et al.,
2010; Alemany et al., 2011; Murray and Jones, 2012). It is also possible
thatmild psychotic symptoms experienced by HR individuals may con-
tribute to the development of other psychiatric disorders.
Notably, people at HR in our and other samples (Bechdolf et al.,
2005; Fusar-Poli et al., 2012; Zimbrón et al., 2012) endorsed a remark-
ably poor global functioning and quality of life, which was particularly
striking when we compared them to healthy volunteers from the
same region. This would justify special attention from mental health
services in order to develop appropriate care pathways for a population
also characterised by a signiﬁcant risk of suicidality, regardless of cur-
rent uncertainties on the mechanisms underlying these presentations.
On the basis of our ﬁndings, clinical interventions in individuals at HR
indentiﬁed in early intervention in psychosis services should aim at
targeting a broader range of psychopathology, especially mood and
anxiety symptoms, rather than just focusing on the treatment and/or
prevention of psychosis.
4.1. Limitations
One of the limitations of the study is its cross-sectional nature,
where causal inferences on the HR state, psychiatric morbidity and
impaired functioning cannot be made. Efforts to follow-up this HR co-
hort are being undertaken in order to assess if HR mental states are
associated with the development of functional difﬁculties and psychi-
atric morbidity. Also, the study only included people aged 16–
35 years, which might affect the generalisability of our results. How-
ever, this is a valuable homogenous cohort with all individuals mainly
suffering from attenuated psychotic symptoms. Furthermore, we did
not match the study groups on educational level, yet the groups did
not differ with respect to age, gender and ethnicity. Finally, we did
not include a chronicity criterion to determine whether people with
longer duration of HR mental state criteria had a different proﬁle of
psychopathology from those with shorter duration.
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